Metabonomic phenotype and identification of "heart blood stasis obstruction pattern" and "qi and yin deficiency pattern" of myocardial ischemia rat models

Science in China, Series C: Life Sciences

Volumn 52, Issue 11, 2009, Pages 1081-1090

  Yan, Bei ^a   A, Ji Ye ^a   Hao, Hai Ping ^a   Wang, Guang Ji ^a   Zhu, Xuan Xuan ^b,c   Zha, Wei Bin ^a   Liu, Lin Sheng ^a   Guan, En Ze ^c   Zhang, Ying ^a   Gu, Sheng Hua ^a   Huang, Qing ^a   Zheng, Yuan Ting ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

GC TOF MS; Heart blood stasis obstruction pattern; Metabonomics; Myocardial ischemia; Qi and yin deficiency pattern; Rat model

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER;

ANIMAL; ARTICLE; CHINESE MEDICINE; DISEASE MODEL; ENERGY METABOLISM; HEART MUSCLE; HEART MUSCLE ISCHEMIA; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOME; METABOLOMICS; METHODOLOGY; OXIDATIVE STRESS; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; MALE; MASS SPECTROMETRY; MEDICINE, CHINESE TRADITIONAL; METABOLOME; METABOLOMICS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OXIDATIVE STRESS; PHENOTYPE; QI; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; YIN DEFICIENCY;

RATTUS;

EID: 73249141246     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-009-0136-y     Document Type: Article

References (42)

1. Chang H. Traditional Chinese Medical Science (in Chinese). Beijing: Xueyuan Press, 2001.
2. Li Y K. Experimental Methodology of Traditional Chinese Drug Pharmacology (in Chinese). Shanghai: Shanghai Science and Technology Press, 1991.
3. Brindle J T, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabolomics. Nat Med, 2002, 8: 1439-1444.
4. Sabatine M S, Liu E, Morrow D A, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation, 2005, 112: 3868-3875.
5. Denkert C, Budczies J, Kind T, et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res, 2006, 66: 10795-10804.
6. Yin P, Zhao X, Li Q, et al. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res, 2006, 5: 2135-2143.
7. Yang J, Zhao X, Liu X, et al. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res, 2006, 5: 554-561.
8. Chen M, Zhao L, Jia W. Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. J Proteome Res, 2005, 4: 2391-2396.
9. Wang C, Kong H, Guan Y, et al. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem, 2005, 77: 4108-4116.
10. Li M, Wang B, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA, 2008, 105: 2117-2122.
11. Luo G H, Ding J, Yue G X, et al. Metabonomic study of syndrome of liver qi stagnation and spleen deficiency in rats (in Chinese). J Chinese Integr Med, 2007, 5: 307-313.
12. Li L, Wang J N, Ren J X. NMR-based metabonomics of "Qi vacuity blood stasis pattern" rat urine. Chinese Sci Bull (in Chinese), 2007, 52: 1758-1762.
13. Zheng X Y. Guidance for traditional Chinese drug research (on trial). Beijing: China Medicine Technology Press, 2002.
14. Qi Y F, Shi Y R, Bu D F, et al. Changes of adrenomedullin and receptor activity modifying protein 2 (RAMP2) in myocardium and aorta in rats with isoproterenol-induced myocardial ischemia. Peptides, 2003, 24: 463-468.
15. Mao T M, Lin J H. Research on pathological models of "blood stasis" (1). J Beijing Med Univ (in Chinese), 1985, 17: 246-248.
16. Zhang C, Sheng X S, Lv R, et al. Study on normalization and standar-dization of animal models with TCM "pattern" myocardial ischemia (2). Shanghai J Trad Chinese Med (in Chinese), 2003, 37: 42-45.
17. A J Trygg J, Gullberg J, Johanssson A I, et al. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem, 2005, 77: 8086-8094.
18. Jonsson P, Johansson A I, Gullberg J, et al. High-Throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem, 2005, 77: 5635-5642.
19. Trygg J, Lundstedt T. Chemometrics techniques for metabonomics. J Proteome Res, 2007, 6: 469-479.
20. Wold S. Cross-validatory estimation of the number of components in factor and principal components models. Technometrics, 1978, 20: 397-405.
21. Wu W T. Biochemistry. Beijing: People's Medical Publishing House, 2001.
22. Silva A R, Ruschel C, Helegda C, et al. Inhibition of in vitro CO2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain. Braz J Med Biol Res, 2001, 34: 627-631.
23. Suzuki M, Suzuki M, Kitamura Y, et al. Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol, 2002, 89: 36-43.
24. Dardzinski B J, Smith S L, Towfighi J, et al. Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain damage during neonatal hypoxia ischemia with dexamethasone pretreatment. Pediatr Res, 2000, 48: 248-255.
25. Leeuwenburgh C, Ji L L. Glutathione depletion in rested and exercised mice: biochemical consequence and adaptation. Arch Biochem Biophys, 1995, 316: 941-949.
26. Anderson M E. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact, 1998, 111-112: 1-14.
27. Thomas M, Hughes R E. A relationship between ascorbic acid and threonic acid in guinea-pigs. Food Chem Toxicol, 1983, 21: 449-452.
28. Miura D, Tanaka H, Wariishi H. Metabolomic differential display analysis of the white-rot basidiomycete Phanerochaete chrysosporium grown under air and 100% oxygen. FEMS Microbiol Lett, 2004, 234: 111-116.
29. Walsh N P, Blannin A K, Robson P J, et al. Glutamine, exercise and immune function. Links and possible mechanisms. Sports Med, 1998, 26: 177-191.
30. Koyama K, Sato T, Omichi N, et al. Relationship between aging and hydroxyproline content of serum in human being. Ann Physiol Anthropol, 1993, 12: 243-249.
31. Banday A A, Farooq N, Priyamvada S, et al, Time dependent effects of gentamicin on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in rat kidney tissues. Life Sci, 2008, 82: 450-459.
32. Omurtag G Z, Tozan A, Sehirli A O, et al, Melatonin protects against endosulfan-induced oxidative tissue damage in rats. J Pineal Res, 2008, 44: 432-438.
33. Kim H, McGrath B M, Silverstone P H. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders-focus on magnetic resonance spectroscopy (MRS) studies. Hum Psychopharmacol, 2005, 20: 309-326.
34. Xing Y L, Yu L Z. Mechanism of sleep deprivation and progress in traditional Chinese medicine and materia medica intervention. Pharmacol Clin Chinese Mater Med (in Chinese), 2003, 19: 47-49.
35. Wang G J, Zha W B, Hao H P, et al. Metabonomics and its application prospect in TCM study. Clin J Nat Med (in Chinese), 2008, 6: 89-97.
36. Liu C X, Ci D Y, Wan R Z, et al. Metabonomics in research of natural drugs and traditional Chinese medicines. Clin J Nat Med (in Chinese), 2008, 6: 82-88.
37. Huang Y R, Wei G L, Long H, et al. Pharmacodynamics and its biochemical mechanism of Uncaria-stem Mistura for hyperactivity syndrome by metabonomic method. Chinese Trad Herb Drugs (in Chinese), 2005, 36: 398-402.
38. Zhou M M, Liu P, Jia W, et al. Evaluation of therapeutic effects of TCM based on metabolic variations. World Sci Technol / Modern Trad Chinese Med Mater Med (in Chinese), 2006, 8: 113-119.
39. Wang X Y, Su M M, Qiu Y P, et al. Metabolic regulatory net-work alterations in response to acute cold stress and ginsenoside intervention. J Proteome Res, 2007, 6: 3449-3455.
40. Li F M, Lu X M, Liu H P, et al. A pharmaco-metabonomic study on the therapeutic basis and metabolic effects of Epimedium brevicornum Maxim. on hydrocortisone-induced rat using UPLC-MS. Biomed Chromatogr, 2007, 21: 397-405.
41. Jiang N, Zhou W X, Zhang Y X. Study on the mechanism of action of Liuwei and Bawei Dihuang decoction by metabonomics. Pharmacol Clin Chinese Mater Med (in Chinese), 2007, 23: 45.
42. Lu Y H, Wang G J, Huang Q, et al. Investigations into metabonomic profiling of spontaneously hypertension rat (SHR) and metabolic effects of total ginsenoside on SHR using GC/MS. Chin J Nat Med (in Chinese), 2007, 11: 443-447.